Novartis is a major player in this field having already made a couple of additions to their company portfolio, reports say they are looking to significantly increase their footprint in this exciting field. Cheryl Maley is ex Novartis where she was highly regarded and I expect still has high level contacts, Jeremy Paul recent met with Novartis representatives at the recent US conference where he was a presenter on Starpharma (was reported). Coincidence? I don’t think so you heard it here first. DYOR google Novartis and Radiopharmaceuticles.
Novartis is a major player in this field having already made a...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.36M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 13.0¢ | $30.60K | 232.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 458760 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 87374 | 5 |
View Market Depth
| Last trade - 15.09pm 05/09/2025 (20 minute delay) ? |
| SPL (ASX) Chart |